UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
September 1, 2005
-------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification
Incorporation) Number)
358 SOUTH MAIN STREET
BURLINGTON, NORTH CAROLINA 27215
--------------------------------------- -------
(Address of principal executive offices) (Zip Code)
336-229-1127
------------
(Registrant's telephone number, including area code)
N/A
---------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. Regulation FD Disclosure
On September 1, 2005 - Laboratory Corporation of America(R) Holdings
(LabCorp(R)) today announced that Bradford T. Smith, Executive Vice
President, Corporate Affairs, and William (Brad) Hayes, Executive Vice
President and Chief Financial Officer, are scheduled to speak at the Thomas
Weisel Partners Healthcare Conference in Boston, MA. LabCorp's presentation
is planned for Wednesday, September 7, 2005 at 3:50 p.m. Eastern Time.
The press release dated September 1, 2005 is attached herewith as Exhibit 99.1.
ITEM 9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit Description
--------- ---------------------------------------------
99.1 Press Release
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
--------------------------------------
Bradford T. Smith
Executive Vice President and Secretary
Date: September 1, 2005
EXHIBIT INDEX
Exhibit Description
--------- ---------------------------------------------
99.1 Press Release